Online inquiry

IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10701MR)

This product GTTS-WK10701MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAMTS17 protein. This product can be used in Oogenesis phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_139057.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 170691
UniProt ID Q8TE56
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAMTS17, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10701MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25934MR IVTScrip™ mRNA-Human ARL13B, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK22648MR IVTScrip™ mRNA-Human ARL6IP4, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARL6IP4
GTTS-WK4967MR IVTScrip™ mRNA-Human TNC, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA TNC
GTTS-WK24093MR IVTScrip™ mRNA-Human ARHGAP29, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARHGAP29
GTTS-WK9270MR IVTScrip™ mRNA-Human ADRBK2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADRBK2
GTTS-WK25037MR IVTScrip™ mRNA-Human ARL16, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL16
GTTS-WK18529MR IVTScrip™ mRNA-Human ANKRD49, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANKRD49
GTTS-WK28091MR IVTScrip™ mRNA-Human ASAP1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASAP1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →